Broccoli seed extract, SULFODYNE, exhibits an antiviral effect in new preclinical study

Published: 6-Jan-2025

The nutraceutical exhibited potent antiviral effects in both in vivo and in vitro studies, suggesting the potential of the plant-based active ingredient sulforaphane in protecting immune health

You need to be a subscriber to read this article.
Click here to find out more.

Ingood by Olga's broccoli seed extract, SULFODYNE, has been proven to act as a COVID-19 antiviral in two novel preclinical studies.1,2

SULFODYNE is a broccoli seed extract standardised and stabilised to 5% active and natural sulforaphane.

The trial, which explored the benefits of the nutraceutical both in vivo and in vitro, found that SULFODYNE can reduce the likelihood of COVID-19 infection via a range of mechanisms.

These results highlight the potential of the functional ingredient in supporting immune health and preventing seasonal viral infections.


Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.

You may also like